Immunologic impairment in patients with non-lymphoid cancer. Correlation with the tumoral stage, response to treatment, and survival
- 1 February 1976
- Vol. 37 (2) , 724-728
- https://doi.org/10.1002/1097-0142(197602)37:2<724::aid-cncr2820370219>3.0.co;2-g
Abstract
The cellular immunity has been studied in 121 patients affected by solid nonlymphoid tumors, and in 50 healthy patients, 11 with benign tumors, with the use of techniques of in vivo dinitrochlorobenzene (DNCB) and in vitro lymphocyte response to phytohemagglutinin to observe the correlation between both tests and the clinical stage of the disease, the response to chemotherapy and surgery, prognosis, and survival. Patients with anergy presented tumoral irresectability, lack of response to chemotherapy, advanced disease, and limited survival. In the patients with good immune response, the disease was limited, responding with greater frequency to therapy and presenting a higher rate of survival. Consequently, the immunologic study of a neoplastic patient can guide us toward a therapeutic behavior and a prognosis.This publication has 32 references indexed in Scilit:
- Personal ViewBMJ, 1972
- REDUCED LYMPHOCYTE TRANSFORMATION IN BREAST CANCERThe Lancet, 1971
- Phytohemagglutinin (PHA)-induced transformation of lymphocytes from patients with cancerCancer, 1971
- Five-year cancer cure: Relation to total amount of peripheral lymphocytes and neutrophilsCancer, 1970
- Human Lymphocyte Migration as a Parameter of HypersensitivityActa Medica Scandinavica, 1967
- Immunochemical quantitation of antigens by single radial immunodiffusionImmunochemistry, 1965
- Immunological defect in aged population and its relationship to cancerCancer, 1965
- DELAYED HYPERSENSITIVITY RESPONSE TO DNFB IN SICK AND HEALTHY PERSONS*Annals of the New York Academy of Sciences, 1964
- STUDIES ON DELAYED HYPERSENSITIVITY IN HODGKIN'S DISEASE*Journal of Clinical Investigation, 1962
- Homotransplantation of Human Cell LinesScience, 1957